A rare nerve pain condition, known as allodynia, has been linked to the use of popular GLP-1 weight-loss drugs like Mounjaro and Ozempic. This condition causes skin to become hypersensitive, leading to pain from stimuli that would not typically be painful, such as light touch or even clothing.
Physicians are investigating a potential connection between the dosage of these medications and the development of allodynia. While not fully understood, the prevailing theory suggests that the high levels of medication may be affecting nerve signals. Patients have described the sensation as their skin feeling "on fire."
One individual, Kaela Knight, documented her experiences with these drugs and the subsequent nerve pain on TikTok, where she has gained a significant following. Knight, who weighs 125 pounds, previously weighed 210 pounds before starting tirzepatide. She has shared her journey, including the development of this unusual side effect, with her followers.
The GLP-1 class of drugs, which includes Ozempic and Mounjaro, has gained widespread popularity for their effectiveness in weight management and for patients with type 2 diabetes. However, as more people use these medications, less common side effects are beginning to emerge and be studied by the medical community.